Propel Bio Management »

Telesat Corp Cl A Cl B shares owned by Propel Bio Management

Quarter-by-quarter ownership of Telesat Corp Cl A Cl B (TSAT) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Telesat Corp Cl A Cl B

Tip: Access up to 7 years of quarterly data

All positions including Telesat Corp Cl A Cl B held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Telesat Corp Cl A Cl B by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.3M 366k 9.10
2024-03-31 $2.5M 291k 8.60
2023-12-31 $3.0M 291k 10.43

More positions owned by Propel Bio Management

Applied Therapeutics Comm (APLT)
Plains Gp Holdings Lp-cl Comm (PAGP)
Tscan Therapeutics Comm (TCRX)
Madrigal Pharmaceuticals Comm (MDGL)
Achieve Life Sciences Comm (ACHV)
Phathom Pharmaceuticals I Comm (PHAT)
Akero Therapeutics Comm (AKRO)
Avidity Biosciences Comm (RNA)
Ardelyx Comm (ARDX)
Abeona Therapeutics Comm (ABEO)
Fulcrum Therapeutics Comm (FULC)
Athira Pharma Comm (ATHA)
Telesat Corp Comm (TSAT)
Verrica Pharmaceuticals I Comm (VRCA)
Kura Oncology Comm (KURA)

View all positions for Propel Bio Management

Top funds holding Telesat Corp Cl A Cl B

MHR Fund Management
GAMCO Asset Management
Heard Capital
Rubric Capital Management
Gabelli Funds
Highland Capital Management Fund Advisors
Simplify Asset Management
Propel Bio Management
Caption Management
Tejara Capital
Gabelli Securities
Citadel Advisors
Susquehanna International
Pathstone Holdings
Connor, Clark & Lunn Investment Management

View all funds holding Telesat Corp Cl A Cl B